(Q46585287)

English

Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

zoledronic acid

1 reference

based on heuristic

inferred from title

author name string

Quinn JE

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Brown LG

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Zhang J

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Keller ET

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Vessella RL

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Corey E

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

253-259

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

Morphometric evidence for bone resorption and replacement in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid: an evolving role in the treatment of cancer patients with bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of C4-2 prostate cancer bone metastases and their response to castration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500815

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.PCAN.4500815

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15999121

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46585287&oldid=2207962107"